Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Spectral Medical Inc
T.EDT
Alternate Symbol(s):
EDTXF
Healthcare
Biotechnology
Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis...
enabler. These devices have large commercial potential
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:EDT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(225)
•••
Revten
X
View Profile
View Bullboard History
Post by
Revten
on Mar 13, 2024 9:26am
Happening Today
CRRT CONFERENCE Industry Breakfast Symposium Sponsored By Spectral Medical https://crrtonline.com/optional-industry-sessions/
(146)
•••
BlueJays9293
X
View Profile
View Bullboard History
Comment by
BlueJays9293
on Mar 13, 2024 1:54am
RE:There was no catalyst, as there is no billion dollar market
We shall see. Now it's just you and me, you saw what happened to your little boy spamme. You better tighten up that jibberish, because I'm coming for you. Thank you. Come again.
Fresh Insight into the Topaz Helium Project's Expected Size and Scale
posted Apr 26, 2024 9:00am by
Pulsar Helium Inc.
-
|
The prospective zone is very broad. We believe its not just an isolated occurrence but is actually something quite regionally extensive ...read more
(146)
•••
BlueJays9293
X
View Profile
View Bullboard History
Comment by
BlueJays9293
on Mar 13, 2024 12:23am
RE:RE:RE:RE:RE:20 cents off last months
Go tell it to the river smarty, I think I speak for most shareholders that we are tired of hearing your constant complaining. Always whining about how you should have worn a wind breaker cuz it&
...more
(146)
•••
BlueJays9293
X
View Profile
View Bullboard History
Comment by
BlueJays9293
on Mar 12, 2024 10:08pm
RE:RE:RE:RE:RE:20 cents off last months
(346)
•••
hmmmmmmmm
X
View Profile
View Bullboard History
Comment by
hmmmmmmmm
on Mar 12, 2024 8:28pm
RE:RE:RE:RE:20 cents off last months
Let's be honest the "pumpers" are not to blame here any more than the so called "bashers". *Most are just corks on the sea, invested in a product they believe in- that
...more
(17)
•••
Bagelboy74
X
View Profile
View Bullboard History
Comment by
Bagelboy74
on Mar 12, 2024 6:18pm
RE:RE:RE:20 cents off last months
Didn't the pumpers just say it will never go into the 40cent range again???? Same old same old. Will have to try what they do and buy at 25 cents and sell at 50. Go Canucks!
(225)
•••
Revten
X
View Profile
View Bullboard History
Post by
Revten
on Mar 12, 2024 4:24pm
TODAY’S NUMBERS
House Positions for C:EDT from 20240312 to 20240312 House Bought $Val Ave Sold $Val Ave Net $Net 2
...more
(225)
•••
Revten
X
View Profile
View Bullboard History
Comment by
Revten
on Mar 12, 2024 3:49pm
RE:A buck 20 off Analyst target?
Like I said when it was at .32 Cents and like I said in the .50 Cent Range....SCREAMING BUY! Nothing has changed except that each day we get that much closer to FDA Approval! A Buy Out?
...more
(346)
•••
hmmmmmmmm
X
View Profile
View Bullboard History
Comment by
hmmmmmmmm
on Mar 12, 2024 3:43pm
RE:A buck 20 off Analyst target?
The only facts that have changed- were changed by management. The 35% drop came from their statements vs their contrary actions. Much like the years of touting DIMI/ SAMI- misleading
...more
(213)
•••
Stocktree
X
View Profile
View Bullboard History
Post by
Stocktree
on Mar 12, 2024 3:08pm
There was no catalyst, as there is no billion dollar market
for EDT. If the trial is a success, this play that isn't shopping around for takers and has proven many times it isn't in the business of producing and selling their goods on their own will
...more
(213)
•••
Stocktree
X
View Profile
View Bullboard History
Comment by
Stocktree
on Mar 12, 2024 2:47pm
RE:RE:20 cents off last months
Haha, the pumping has restarted, now that the dumping is done. And you can't dump if you truly believe what the pumpcycles are advocating. Proof again that this is not a true market opportunity
...more
(862)
•••
mercedesman
X
View Profile
View Bullboard History
Post by
mercedesman
on Mar 12, 2024 2:43pm
A buck 20 off Analyst target?
As far as I know, the facts haven't changed for this almost " completely off the radar " play. Sub $100M USD MC for a company that may soon tap into a $2B US market?
...more
(862)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Mar 12, 2024 2:36pm
RE:20 cents off last months
Great short term buying opportunity for those that sold some in the sixties ? MM
(72)
•••
TechOne
X
View Profile
View Bullboard History
Post by
TechOne
on Mar 12, 2024 1:43pm
Spectral on Linkedin
In July 2022, the U.S. FDA granted Breakthrough Device Designation for PMX for the treatment of endotoxic septic shock. Approximately 330,000 patients are diagnosed with septic shock in North America
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study